{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T20:25:04Z","timestamp":1793737504486,"version":"4.6.1"},"reference-count":177,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T00:00:00Z","timestamp":1722816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004489","name":"Mitacs","doi-asserted-by":"publisher","award":["IT40698"],"award-info":[{"award-number":["IT40698"]}],"id":[{"id":"10.13039\/501100004489","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological and Toxicological Methods"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.vascn.2024.107548","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T20:26:55Z","timestamp":1722630415000},"page":"107548","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Understanding lymphatic drug delivery through chylomicron blockade: A retrospective and prospective analysis"],"prefix":"10.1016","volume":"129","author":[{"given":"Malaz","family":"Yousef","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Bou-Chacra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raimar","family":"L\u00f6benberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal M.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vascn.2024.107548_bb0005","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2174\/18755704MTA48NTcpw","article-title":"Quetiapine fumarate loaded nanostructured lipid carrier for enhancing oral bioavailability: Design, development and pharmacokinetic assessment","volume":"18","author":"Agarwal","year":"2021","journal-title":"Current Drug Delivery"},{"key":"10.1016\/j.vascn.2024.107548_bb0010","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejpb.2023.10.016","article-title":"Pharmacokinetics of cycloheximide in rats and evaluation of its effect as a blocker of intestinal lymph formation","volume":"193","author":"Al Nebaihi","year":"2023","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"key":"10.1016\/j.vascn.2024.107548_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2024.114392","article-title":"Evaluation of the pharmacokinetics, chylomicron inhibition, and toxicity of colchicine in rats given low doses","volume":"202","author":"Al Nebaihi","year":"2024","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"issue":"11","key":"10.1016\/j.vascn.2024.107548_bb0020","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.3390\/pr9112007","article-title":"Liquid chromatography tandem mass spectrometric analytical method for study of colchicine in rats given low doses","volume":"9","author":"Al Nebaihi","year":"2021","journal-title":"Processes"},{"issue":"3","key":"10.1016\/j.vascn.2024.107548_bb0025","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3390\/pharmaceutics9030035","article-title":"Pharmacokinetic and toxicodynamic characterization of a novel doxorubicin derivative","volume":"9","author":"Alrushaid","year":"2017","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.vascn.2024.107548_bb0030","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0005-2760(76)90150-8","article-title":"Lipid transport across the intestinal epithelial cell. Effect of colchicine","volume":"431","author":"Arreaza","year":"1976","journal-title":"Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism"},{"key":"10.1016\/j.vascn.2024.107548_bb0035","first-page":"4797","article-title":"Niosomal carriers enhance oral bioavailability of carvedilol: Effects of bile salt-enriched vesicles and carrier surface charge","volume":"10","author":"Arzani","year":"2015","journal-title":"International Journal of Nanomedicine"},{"issue":"5","key":"10.1016\/j.vascn.2024.107548_bb0040","first-page":"24","article-title":"First extended-release injectable drug therapy for HIV","volume":"121","author":"Aschenbrenner","year":"2021","journal-title":"American Journal of Nursing"},{"issue":"43","key":"10.1016\/j.vascn.2024.107548_bb0045","doi-asserted-by":"crossref","first-page":"17498","DOI":"10.1073\/pnas.1313839110","article-title":"Oral delivery system prolongs blood circulation of docetaxel nanocapsules via lymphatic absorption","volume":"110","author":"Attili-Qadri","year":"2013","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"24","key":"10.1016\/j.vascn.2024.107548_bb0050","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.3748\/wjg.15.2987","article-title":"Pluronic L-81 ameliorates diabetic symptoms in db\/db mice through transcriptional regulation of microsomal triglyceride transfer protein","volume":"15","author":"Au","year":"2009","journal-title":"World Journal of Gastroenterology: WJG"},{"issue":"10","key":"10.1016\/j.vascn.2024.107548_bb0055","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1021\/acs.molpharmaceut.8b00382","article-title":"Exploring Peyer\u2019s patch uptake as a strategy for targeted lung delivery of polymeric rifampicin nanoparticles","volume":"15","author":"Bachhav","year":"2018","journal-title":"Molecular Pharmaceutics"},{"issue":"1","key":"10.1016\/j.vascn.2024.107548_bb0060","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/1567201812666150120153357","article-title":"Development and pharmacokinetic evaluation of industrially viable self-microemulsifying drug delivery systems (SMEDDS) for terbinafine","volume":"13","author":"Baheti","year":"2016","journal-title":"Current Drug Delivery"},{"issue":"31","key":"10.1016\/j.vascn.2024.107548_bb0065","doi-asserted-by":"crossref","first-page":"6234","DOI":"10.1039\/D1TB00806D","article-title":"Insulin-and cholic acid-loaded zein\/casein\u2013dextran nanoparticles enhance the oral absorption and hypoglycemic effect of insulin","volume":"9","author":"Bao","year":"2021","journal-title":"Journal of Materials Chemistry B"},{"key":"10.1016\/j.vascn.2024.107548_bb0070","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1023\/A:1011964213024","article-title":"Effects of pluronic block copolymers on dug absorption in Caco-2 cell monolayers","volume":"15","author":"Batrakova","year":"1998","journal-title":"Pharmaceutical Research"},{"issue":"1","key":"10.1016\/j.vascn.2024.107548_bb0075","first-page":"97","article-title":"Intestinal lymphatic absorption of labelled oleic acid in the normal rat and rat treated with actidione-cycloheximide or acetoxycycloheximide","volume":"292","author":"Bernard","year":"1981","journal-title":"Comptes Rendus des Seances de L\u2019academie des sciences. Serie III, Sciences De La Vie"},{"issue":"9","key":"10.1016\/j.vascn.2024.107548_bb0080","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/nrgastro.2017.79","article-title":"Intestinal lymphatic vasculature: Structure, mechanisms and functions","volume":"14","author":"Bernier-Latmani","year":"2017","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"issue":"7","key":"10.1016\/j.vascn.2024.107548_bb0085","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.3109\/10717544.2015.1037969","article-title":"In-vivo bioavailability and lymphatic uptake evaluation of lipid nanoparticulates of darunavir","volume":"23","author":"Bhalekar","year":"2016","journal-title":"Drug Delivery"},{"issue":"1","key":"10.1016\/j.vascn.2024.107548_bb0090","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1042\/bj2830081","article-title":"Effect of intestinal chylomicron secretory blockade on apolipoprotein synthesis in the newborn piglet","volume":"283","author":"Black","year":"1992","journal-title":"Biochemical Journal"},{"issue":"3","key":"10.1016\/j.vascn.2024.107548_bb0095","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0005-2760(77)90170-9","article-title":"Effect of polyol detergents on cholesterol and triglyceride absorption: hypolipidemic action of chronic administration of hydrophobic detergent","volume":"489","author":"Bochenek","year":"1977","journal-title":"Biochimica et Biophysica Acta (BBA)-Lipids and Lipid Metabolism"},{"issue":"17","key":"10.1016\/j.vascn.2024.107548_bb0100","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S1359-6446(05)03536-1","article-title":"Keynote review: Intestinal Peyer\u2019s patch M cells and oral vaccine targeting","volume":"10","author":"Brayden","year":"2005","journal-title":"Drug Discovery Today"},{"issue":"1","key":"10.1016\/j.vascn.2024.107548_bb0105","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/cphy.c180015","article-title":"Lymphatic vessel network structure and physiology","volume":"9","author":"Breslin","year":"2018","journal-title":"Comprehensive Physiology"},{"issue":"1s","key":"10.1016\/j.vascn.2024.107548_bb0110","doi-asserted-by":"crossref","first-page":"254s","DOI":"10.18433\/jpps30217","article-title":"Lymphatic drug absorption via the enterocytes: Pharmacokinetic simulation, modeling, and considerations for optimal drug development","volume":"21","author":"Brocks","year":"2018","journal-title":"Journal of Pharmacy & Pharmaceutical Sciences"},{"issue":"1","key":"10.1016\/j.vascn.2024.107548_bb0115","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1528-1167.2012.03725.x","article-title":"Tolerability, pharmacokinetics, and bioequivalence of the tablet and syrup formulations of lacosamide in plasma, saliva, and urine: Saliva as a surrogate of pharmacokinetics in the central compartment","volume":"54","author":"Cawello","year":"2012","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.vascn.2024.107548_bb0120","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1080\/01926230600865531","article-title":"Normal structure, function, and histology of mucosa-associated lymphoid tissue","volume":"34","author":"Cesta","year":"2006","journal-title":"Toxicologic Pathology"},{"issue":"1","key":"10.1016\/j.vascn.2024.107548_bb0125","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1208\/s12249-010-9559-9","article-title":"Development and evaluation of chitosan-coated liposomes for oral DNA vaccine: The improvement of Peyer\u2019s patch targeting using a Polyplex-loaded liposomes","volume":"12","author":"Channarong","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.vascn.2024.107548_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2020.101899","article-title":"Nano lipid based carriers for lymphatic voyage of anti-cancer drugs: An insight into the in-vitro, ex-vivo, in-situ and in-vivo study models","volume":"59","author":"Chaturvedi","year":"2020","journal-title":"Journal of Drug Delivery Science and Technology"},{"issue":"1\u20132","key":"10.1016\/j.vascn.2024.107548_bb0135","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ijpharm.2007.08.052","article-title":"Hepatobiliary excretion and enterohepatic circulation of colchicine in rats","volume":"350","author":"Chen","year":"2008","journal-title":"International Journal of Pharmaceutics"},{"issue":"3","key":"10.1016\/j.vascn.2024.107548_bb0140","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jcmgh.2018.12.002","article-title":"The intestinal lymphatic system: Functions and metabolic implications","volume":"7","author":"Cifarelli","year":"2019","journal-title":"Cellular and Molecular Gastroenterology and Hepatology"},{"issue":"1","key":"10.1016\/j.vascn.2024.107548_bb0145","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0016-5085(88)90318-6","article-title":"D-xylose testing: A review","volume":"95","author":"Craig","year":"1988","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.vascn.2024.107548_bb0150","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ejps.2004.12.006","article-title":"Evaluation of a chylomicron flow blocking approach to investigate the intestinal lymphatic transport of lipophilic drugs","volume":"24","author":"Dahan","year":"2005","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.vascn.2024.107548_bb0155","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1007\/s11095-006-9054-x","article-title":"Use of a dynamic in vitro lipolysis model to rationalize oral formulation development for poor water soluble drugs: Correlation with in vivo data and the relationship to intra-enterocyte processes in rats","volume":"23","author":"Dahan","year":"2006","journal-title":"Pharmaceutical Research"},{"issue":"2","key":"10.1016\/j.vascn.2024.107548_bb0160","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/bjd.15896","article-title":"Colchicine: An ancient drug with novel applications","volume":"178","author":"Dasgeb","year":"2018","journal-title":"British Journal of Dermatology"},{"issue":"3","key":"10.1016\/j.vascn.2024.107548_bb0165","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0278-6915(00)00136-8","article-title":"Anatomical and physiological parameters affecting gastrointestinal absorption in humans and rats","volume":"39","author":"DeSesso","year":"2001","journal-title":"Food and Chemical Toxicology"},{"issue":"6","key":"10.1016\/j.vascn.2024.107548_bb0170","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.3390\/nu11061299","article-title":"Effect of nutrient and micronutrient intake on chylomicron production and postprandial lipemia","volume":"11","author":"Desmarchelier","year":"2019","journal-title":"Nutrients"},{"issue":"1\u20132","key":"10.1016\/j.vascn.2024.107548_bb0175","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ijpharm.2015.05.039","article-title":"Novel self-nanoemulsifying self-nanosuspension (SNESNS) for enhancing oral bioavailability of diacerein: Simultaneous portal blood absorption and lymphatic delivery","volume":"490","author":"El-Laithy","year":"2015","journal-title":"International Journal of Pharmaceutics"},{"issue":"1","key":"10.1016\/j.vascn.2024.107548_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11095-017-2307-z","article-title":"Bioactive-chylomicrons for oral lymphatic targeting of Berberine chloride: Novel flow-blockage assay in tissue-based and Caco-2 cell line models","volume":"35","author":"Elsheikh","year":"2018","journal-title":"Pharmaceutical Research"},{"key":"10.1016\/j.vascn.2024.107548_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-021-02112-9","article-title":"Nanoemulsomes for enhanced oral bioavailability of the anticancer phytochemical andrographolide: Characterization and pharmacokinetics","volume":"22","author":"Elsheikh","year":"2021","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.vascn.2024.107548_bb0190","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jconrel.2021.12.003","article-title":"Smart design approaches for orally administered lipophilic prodrugs to promote lymphatic transport","volume":"341","author":"Elz","year":"2022","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/j.vascn.2024.107548_bib881","doi-asserted-by":"crossref","first-page":"124518","DOI":"10.1016\/j.ijpharm.2024.124518","article-title":"Bile salt integrated cerasomes: A potential nanocarrier for enhancement of the oral bioavailability of idarubicin hydrochloride","volume":"662","author":"Emzhik","year":"2024","journal-title":"International Journal of Pharmaceutics"},{"issue":"6","key":"10.1016\/j.vascn.2024.107548_bb0195","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.addr.2011.12.009","article-title":"Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers","volume":"64","author":"Ensign","year":"2012","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"11","key":"10.1016\/j.vascn.2024.107548_bb0200","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1194\/jlr.M600211-JLR200","article-title":"Pluronic L81 enhances triacylglycerol accumulation in the cytosol and inhibits chylomicron secretion","volume":"47","author":"Fatma","year":"2006","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/j.vascn.2024.107548_bb0205","series-title":"Guidance for industry: estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers","author":"FDA","year":"2005"},{"key":"10.1016\/j.vascn.2024.107548_bb0210","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jconrel.2021.05.028","article-title":"In vitro models replicating the human intestinal epithelium for absorption and metabolism studies: A systematic review","volume":"335","author":"Fedi","year":"2021","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/j.vascn.2024.107548_bb0215","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.addr.2016.04.007","article-title":"50 years of oral lipid-based formulations: Provenance, progress and future perspectives","volume":"101","author":"Feeney","year":"2016","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/j.vascn.2024.107548_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121947","article-title":"Vegetable oils composition affects the intestinal lymphatic transport and systemic bioavailability of co-administered lipophilic drug cannabidiol","volume":"624","author":"Feng","year":"2022","journal-title":"International Journal of Pharmaceutics"},{"issue":"5","key":"10.1016\/j.vascn.2024.107548_bb0225","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3109\/15563650.2010.495348","article-title":"Colchicine poisoning: The dark side of an ancient drug","volume":"48","author":"Finkelstein","year":"2010","journal-title":"Clinical Toxicology"},{"issue":"1","key":"10.1016\/j.vascn.2024.107548_bb0230","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ijpharm.2013.01.065","article-title":"Nimodipine nanocrystals for oral bioavailability improvement: Role of mesenteric lymph transport in the oral absorption","volume":"448","author":"Fu","year":"2013","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.vascn.2024.107548_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123734","article-title":"Dual strategy to improve the oral bioavailability of efavirenz employing nanomicelles and curcumin as a bio-enhancer","volume":"651","author":"Fuentes","year":"2024","journal-title":"International Journal of Pharmaceutics"},{"issue":"2","key":"10.1016\/j.vascn.2024.107548_bb0240","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jconrel.2010.10.013","article-title":"Nanoemulsion improves the oral absorption of candesartan cilexetil in rats: Performance and mechanism","volume":"149","author":"Gao","year":"2011","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/j.vascn.2024.107548_bb0245","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.colsurfb.2016.02.012","article-title":"Systematic development of solid self-nanoemulsifying oily formulations (S-SNEOFs) for enhancing the oral bioavailability and intestinal lymphatic uptake of lopinavir","volume":"141","author":"Garg","year":"2016","journal-title":"Colloids and Surfaces B: Biointerfaces"},{"issue":"15","key":"10.1016\/j.vascn.2024.107548_bb0250","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.3390\/polym14153220","article-title":"A QbD approach to design and to optimize the self-emulsifying resveratrol\u2013phospholipid complex to enhance drug bioavailability through lymphatic transport","volume":"14","author":"Gausuzzaman","year":"2022","journal-title":"Polymers"},{"key":"10.1016\/j.vascn.2024.107548_bb0255","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0074-7696(08)61346-7","article-title":"M cells in Peyer\u2019s patches of the intestine","volume":"167","author":"Gebert","year":"1996","journal-title":"International Review of Cytology"},{"issue":"5","key":"10.1016\/j.vascn.2024.107548_bb0260","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ejps.2005.07.011","article-title":"Uptake of lipophilic drugs by plasma derived isolated chylomicrons: Linear correlation with intestinal lymphatic bioavailability","volume":"26","author":"Gershkovich","year":"2005","journal-title":"European Journal of Pharmaceutical Sciences"},{"issue":"2","key":"10.1016\/j.vascn.2024.107548_bb0265","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0022-2275(20)41566-4","article-title":"Chylomicron apoprotein localization within rat intestinal epithelium: Studies of normal and impaired lipid absorption 1","volume":"19","author":"Glickman","year":"1978","journal-title":"Journal of Lipid Research"},{"issue":"11","key":"10.1016\/j.vascn.2024.107548_bb0270","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1172\/JCI107487","article-title":"Lymph chylomicron formation during the inhibition of protein synthesis. Studies of chylomicron apoproteins","volume":"52","author":"Glickman","year":"1973","journal-title":"The Journal of Clinical Investigation"},{"issue":"2","key":"10.1016\/j.vascn.2024.107548_bb0275","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1172\/JCI106821","article-title":"Fat absorption during inhibition of protein synthesis: Studies of lymph chylomicrons","volume":"51","author":"Glickman","year":"1972","journal-title":"The Journal of Clinical Investigation"},{"issue":"3","key":"10.1016\/j.vascn.2024.107548_bb0280","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0016-5085(76)80145-X","article-title":"Intestinal lipoprotein formation: Effect of cholchicine","volume":"70","author":"Glickman","year":"1976","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.vascn.2024.107548_bb0285","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1080\/10837450.2022.2070644","article-title":"Enhanced dissolution and bioavailability of revaprazan using self-nanoemulsifying drug delivery system","volume":"27","author":"Goo","year":"2022","journal-title":"Pharmaceutical Development and Technology"},{"key":"10.1016\/j.vascn.2024.107548_bb0290","series-title":"A manual of adverse drug interactions","author":"Griffin","year":"1997"},{"issue":"5","key":"10.1016\/j.vascn.2024.107548_bb0295","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1007\/s13346-021-01014-4","article-title":"Quality by design (QbD)\u2013based fabrication of atazanavir-loaded nanostructured lipid carriers for lymph targeting: Bioavailability enhancement using chylomicron flow block model and toxicity studies","volume":"12","author":"Gurumukhi","year":"2022","journal-title":"Drug Delivery and Translational Research"},{"issue":"2","key":"10.1016\/j.vascn.2024.107548_bb0300","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/jps.24670","article-title":"Constitutive triglyceride turnover into the mesenteric lymph is unable to support efficient lymphatic transport of a biomimetic triglyceride prodrug","volume":"105","author":"Han","year":"2016","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"5","key":"10.1016\/j.vascn.2024.107548_bb0305","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/intimm\/dxv012","article-title":"Lymph formation, composition and circulation: A proteomics perspective","volume":"27","author":"Hansen","year":"2015","journal-title":"International Immunology"},{"issue":"3","key":"10.1016\/j.vascn.2024.107548_bb0310","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s40264-022-01265-1","article-title":"Colchicine drug interaction errors and misunderstandings: Recommendations for improved evidence-based management","volume":"46","author":"Hansten","year":"2023","journal-title":"Drug Safety"},{"key":"10.1016\/j.vascn.2024.107548_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2023.113148","article-title":"TPGS decorated NLC shift gefitinib from portal absorption into lymphatic delivery: Intracellular trafficking, biodistribution and bioavailability studies","volume":"223","author":"Harisa","year":"2023","journal-title":"Colloids and Surfaces B: Biointerfaces"},{"issue":"9","key":"10.1016\/j.vascn.2024.107548_bb0320","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0022-2275(20)42345-4","article-title":"Transport of lipid and apolipoproteins AI and A-IV in intestinal lymph of the rat","volume":"31","author":"Hayashi","year":"1990","journal-title":"Journal of Lipid Research"},{"issue":"22","key":"10.1016\/j.vascn.2024.107548_bb0325","doi-asserted-by":"crossref","first-page":"1800711","DOI":"10.1002\/adhm.201800711","article-title":"Bioimaging of intact polycaprolactone nanoparticles using aggregation-caused quenching probes: Size-dependent translocation via oral delivery","volume":"7","author":"He","year":"2018","journal-title":"Advanced Healthcare Materials"},{"issue":"5","key":"10.1016\/j.vascn.2024.107548_bb0330","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/MOL.0000000000000626","article-title":"Intestinal lymphatic vessels and their role in chylomicron absorption and lipid homeostasis","volume":"30","author":"Hokkanen","year":"2019","journal-title":"Current Opinion in Lipidology"},{"issue":"1","key":"10.1016\/j.vascn.2024.107548_bb0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9150(99)00397-4","article-title":"A proposed model for the assembly of chylomicrons","volume":"148","author":"Hussain","year":"2000","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.vascn.2024.107548_bb0340","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1248\/bpb.29.508","article-title":"Disposition of lipid-based formulation in the intestinal tract affects the absorption of poorly water-soluble drugs","volume":"29","author":"Iwanaga","year":"2006","journal-title":"Biological and Pharmaceutical Bulletin"},{"issue":"1","key":"10.1016\/j.vascn.2024.107548_bb0345","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s13346-023-01386-9","article-title":"Enhanced tissue distribution of ritonavir-loaded nanostructured lipid carriers\u2014Recommending its dose reduction","volume":"14","author":"Jitta","year":"2024","journal-title":"Drug Delivery and Translational Research"},{"issue":"1","key":"10.1016\/j.vascn.2024.107548_bb0350","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0005-2760(69)90070-8","article-title":"The absorption and metabolism of short and long chain fatty acids in puromycin-treated rats","volume":"176","author":"Kayden","year":"1969","journal-title":"Biochimica et Biophysica Acta (BBA)-Lipids and Lipid Metabolism"},{"key":"10.1016\/j.vascn.2024.107548_bb0355","first-page":"2733","article-title":"Advanced ddrug delivery to the lymphatic system: Lipid-based nanoformulations","volume":"8","author":"Khan","year":"2013","journal-title":"International Journal of Nanomedicine"},{"issue":"2","key":"10.1016\/j.vascn.2024.107548_bb0360","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ajps.2013.07.012","article-title":"Liposomal formulations for enhanced lymphatic drug delivery","volume":"8","author":"Kim","year":"2013","journal-title":"Asian Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.vascn.2024.107548_bb0365","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.3389\/fimmu.2019.02345","article-title":"The roles of Peyer\u2019s patches and microfold cells in the gut immune system: Relevance to autoimmune diseases","volume":"10","author":"Kobayashi","year":"2019","journal-title":"Frontiers in Immunology"},{"issue":"2","key":"10.1016\/j.vascn.2024.107548_bb0370","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0006-2952(79)90508-2","article-title":"Serum lipid-lowering effect of vinca alkaloids","volume":"28","author":"Kremmer","year":"1979","journal-title":"Biochemical Pharmacology"},{"issue":"5","key":"10.1016\/j.vascn.2024.107548_bb0375","first-page":"1","article-title":"Cardiovascular system: Anatomy and physiology","volume":"2","author":"Kroeker","year":"2018","journal-title":"Cardiovascular Mechanics"},{"issue":"1","key":"10.1016\/j.vascn.2024.107548_bb0380","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1021\/mp9001816","article-title":"Formulation and characterization of echogenic lipid\u2212 pluronic nanobubbles","volume":"7","author":"Krupka","year":"2010","journal-title":"Molecular Pharmaceutics"},{"issue":"15","key":"10.1016\/j.vascn.2024.107548_bb0385","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.2174\/1568026615666150414120547","article-title":"Drug delivery systems and combination therapy by using vinca alkaloids","volume":"15","author":"Lee","year":"2015","journal-title":"Current Topics in Medicinal Chemistry"},{"issue":"49","key":"10.1016\/j.vascn.2024.107548_bb0390","doi-asserted-by":"crossref","first-page":"42492","DOI":"10.1021\/acsami.7b11821","article-title":"Influence of particle geometry on gastrointestinal transit and absorption following oral administration","volume":"9","author":"Li","year":"2017","journal-title":"ACS Applied Materials & Interfaces"},{"issue":"3","key":"10.1016\/j.vascn.2024.107548_bb0395","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.apsb.2017.02.002","article-title":"Self-microemulsifying drug delivery system for improving the bioavailability of huperzine A by lymphatic uptake","volume":"7","author":"Li","year":"2017","journal-title":"Acta Pharmaceutica Sinica B"},{"issue":"4","key":"10.1016\/j.vascn.2024.107548_bb0400","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1080\/03639045.2020.1735408","article-title":"A matrix dispersion based on phospholipid complex system: Preparation, lymphatic transport, and pharmacokinetics","volume":"46","author":"Li","year":"2020","journal-title":"Drug Development and Industrial Pharmacy"},{"key":"10.1016\/j.vascn.2024.107548_bb0405","doi-asserted-by":"crossref","first-page":"7291","DOI":"10.2147\/IJN.S214883","article-title":"Oral absorption and lymphatic transport of baicalein following drug\u2013phospholipid complex incorporation in self-microemulsifying drug delivery systems","volume":"14","author":"Liao","year":"2019","journal-title":"International Journal of Nanomedicine"},{"key":"10.1016\/j.vascn.2024.107548_bb0410","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.2147\/IJN.S408115","article-title":"Self-nanoemulsifying drug delivery system for enhanced bioavailability of madecassic acid: In vitro and in vivo evaluation","volume":"18","author":"Lin","year":"2023","journal-title":"International Journal of Nanomedicine"},{"issue":"13","key":"10.1016\/j.vascn.2024.107548_bb0415","doi-asserted-by":"crossref","first-page":"1809015","DOI":"10.1002\/adfm.201809015","article-title":"Phase-changeable nanoemulsions for oral delivery of a therapeutic peptide: Toward targeting the pancreas for antidiabetic treatments using lymphatic transport","volume":"29","author":"Lin","year":"2019","journal-title":"Advanced Functional Materials"},{"issue":"3","key":"10.1016\/j.vascn.2024.107548_bb0420","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ejps.2008.07.003","article-title":"Intestinal lymphatic transport of halofantrine in rats assessed using a chylomicron flow blocking approach: The influence of polysorbate 60 and 80","volume":"35","author":"Lind","year":"2008","journal-title":"European Journal of Pharmaceutical Sciences"},{"issue":"1","key":"10.1016\/j.vascn.2024.107548_bb0425","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0378-5173(94)00336-4","article-title":"Mechanism of promotion of lymphatic drug absorption by milk fat globule membrane","volume":"118","author":"Liu","year":"1995","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.vascn.2024.107548_bb0430","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.2147\/IJN.S442143","article-title":"Lipid-based self-microemulsion of niclosamide achieved enhanced oral delivery and anti-tumor efficacy in orthotopic patient-derived xenograft of hepatocellular carcinoma in mice","volume":"19","author":"Liu","year":"2024","journal-title":"International Journal of Nanomedicine"},{"issue":"1\u20132","key":"10.1016\/j.vascn.2024.107548_bb0435","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijpharm.2015.02.017","article-title":"Biomimetic reassembled chylomicrons as novel association model for the prediction of lymphatic transportation of highly lipophilic drugs via the oral route","volume":"483","author":"Lu","year":"2015","journal-title":"International Journal of Pharmaceutics"},{"issue":"1","key":"10.1016\/j.vascn.2024.107548_bb0440","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ijpharm.2015.09.014","article-title":"Solid lipid nanoparticles (SLN) of efavirenz as lymph targeting drug delivery system: Elucidation of mechanism of uptake using chylomicron flow blocking approach","volume":"495","author":"Makwana","year":"2015","journal-title":"International Journal of Pharmaceutics"},{"issue":"8","key":"10.1016\/j.vascn.2024.107548_bb0445","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1080\/17425247.2018.1503249","article-title":"Targeting the intestinal lymphatic system: A versatile path for enhanced oral bioavailability of drugs","volume":"15","author":"Managuli","year":"2018","journal-title":"Expert Opinion on Drug Delivery"},{"issue":"9","key":"10.1016\/j.vascn.2024.107548_bb0450","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.3390\/ijms21093248","article-title":"Lipids and lipid-processing pathways in drug delivery and therapeutics","volume":"21","author":"Markovic","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"issue":"17","key":"10.1016\/j.vascn.2024.107548_bb0455","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1016\/j.bmcl.2018.06.044","article-title":"Vinca alkaloids and analogues as anti-cancer agents: Looking back, peering ahead","volume":"28","author":"Martino","year":"2018","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"issue":"1","key":"10.1016\/j.vascn.2024.107548_bb0460","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.semarthrit.2020.11.007","article-title":"A systematic review of the infectious complications of colchicine and the use of colchicine to treat infections","volume":"51","author":"McEwan","year":"2021","journal-title":"Seminars in Arthritis and Rheumatism"},{"key":"10.1016\/j.vascn.2024.107548_bb0465","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-020-01855-1","article-title":"Paclitaxel-loaded colloidal silica and TPGS-based solid self-emulsifying system interferes Akt\/MTOR pathway in MDA-MB-231 and demonstrates anti-tumor effect in syngeneic mammary tumors","volume":"21","author":"Meher","year":"2020","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.vascn.2024.107548_bb0470","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/351693","article-title":"Intestinal lymphatic delivery of praziquantel by solid lipid nanoparticles: Formulation design, in vitro and in vivo studies","volume":"2014","author":"Mishra","year":"2014","journal-title":"Journal of Nanotechnology"},{"issue":"4","key":"10.1016\/j.vascn.2024.107548_bb0475","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000198754","article-title":"Effect of colchicine on intestinal alkaline phosphatase activity during linoleic acid absorption in rats","volume":"23","author":"Miura","year":"1982","journal-title":"Digestion"},{"issue":"3","key":"10.1016\/j.vascn.2024.107548_bb0480","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2302\/kjm.28.121","article-title":"Studies on the difference of lymphatic absorption between saturated and unsaturated long chain fatty acids in rats particularly in reference with the effect of puromycin and colchicine","volume":"28","author":"Miura","year":"1979","journal-title":"The Keio Journal of Medicine"},{"key":"10.1016\/j.vascn.2024.107548_bb0485","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-021-02680-4","article-title":"Puromycin-based purification of cells with high expression of the cytochrome P450 CYP3A4 gene from a patient with drug-induced liver injury (DILI)","volume":"13","author":"Miyata","year":"2022","journal-title":"Stem Cell Research & Therapy"},{"key":"10.1016\/j.vascn.2024.107548_bb0490","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1146\/annurev-fluid-122316-045259","article-title":"Lymphatic system flows","volume":"50","author":"Moore","year":"2018","journal-title":"Annual Review of Fluid Mechanics"},{"issue":"1","key":"10.1016\/j.vascn.2024.107548_bb0495","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0009-3084(03)00090-2","article-title":"Pluronic L81 affects the lipid particle sizes and apolipoprotein B conformation","volume":"126","author":"Morita","year":"2003","journal-title":"Chemistry and Physics of Lipids"},{"issue":"11","key":"10.1016\/j.vascn.2024.107548_bb0500","first-page":"1231","article-title":"Vinca alkaloids","volume":"4","author":"Moudi","year":"2013","journal-title":"International Journal of Preventive Medicine"},{"issue":"1","key":"10.1016\/j.vascn.2024.107548_bb0505","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s11671-023-03954-x","article-title":"Fabrication of TPGS decorated etravirine loaded lipidic nanocarriers as a neoteric oral bioavailability enhancer for lymphatic targeting","volume":"19","author":"Muheem","year":"2024","journal-title":"Discover Nano"},{"issue":"3","key":"10.1016\/j.vascn.2024.107548_bb0510","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1080\/03639045.2020.1724128","article-title":"Enhanced bioavailability and antihypertensive activity of nisoldipine loaded nanoemulsion: Optimization, cytotoxicity and uptake across Caco-2 cell line, pharmacokinetic and Pharmacodynamic studies","volume":"46","author":"Mundada","year":"2020","journal-title":"Drug Development and Industrial Pharmacy"},{"issue":"4","key":"10.1016\/j.vascn.2024.107548_bb0515","doi-asserted-by":"crossref","first-page":"G583","DOI":"10.1152\/ajpgi.00482.2002","article-title":"Intestinal alkaline phosphatase release is not associated with chylomicron formation","volume":"284","author":"Nauli","year":"2003","journal-title":"American Journal of Physiology. Gastrointestinal and Liver Physiology"},{"issue":"6","key":"10.1016\/j.vascn.2024.107548_bb0520","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jbspin.2006.03.006","article-title":"Colchicine today","volume":"73","author":"Niel","year":"2006","journal-title":"Joint, Bone, Spine"},{"issue":"3","key":"10.1016\/j.vascn.2024.107548_bb0525","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0005-2760(89)90084-2","article-title":"Further studies on the mechanism of inhibition of intestinal chylomicron transport by pluronic L-81","volume":"1004","author":"Nutting","year":"1989","journal-title":"Biochimica et Biophysica Acta (BBA)-Lipids and Lipid Metabolism"},{"issue":"2\u20133","key":"10.1016\/j.vascn.2024.107548_bb0530","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jconrel.2003.10.018","article-title":"Micellar formulations for drug delivery based on mixtures of hydrophobic and hydrophilic pluronic\u00ae block copolymers","volume":"94","author":"Oh","year":"2004","journal-title":"Journal of Controlled Release"},{"issue":"7","key":"10.1016\/j.vascn.2024.107548_bb0535","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1440-1681.2004.04012.x","article-title":"Comparative bioavailability of two cefadroxil products using serum and urine data in healthy human volunteers","volume":"31","author":"Otoom","year":"2004","journal-title":"Clinical and Experimental Pharmacology & Physiology"},{"key":"10.1016\/j.vascn.2024.107548_bb0540","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-018-1212-z","article-title":"Novel drug delivery approach via self-microemulsifying drug delivery system for enhancing oral bioavailability of asenapine maleate: Optimization, characterization, cell uptake, and in vivo pharmacokinetic studies","volume":"20","author":"Patel","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.vascn.2024.107548_bb0545","doi-asserted-by":"crossref","first-page":"105027","DOI":"10.1016\/j.ejps.2019.105027","article-title":"Self microemulsifying drug delivery system of Lurasidone hydrochloride for enhanced oral bioavailability by lymphatic targeting: In vitro, Caco-2 cell line and in vivo evaluation","volume":"138","author":"Patel","year":"2019","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.vascn.2024.107548_bb0550","doi-asserted-by":"crossref","first-page":"105715","DOI":"10.1016\/j.ejps.2021.105715","article-title":"Enhanced oral bioavailability of nintedanib esylate with nanostructured lipid carriers by lymphatic targeting: In vitro, cell line and in vivo evaluation","volume":"159","author":"Patel","year":"2021","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.vascn.2024.107548_bb0555","doi-asserted-by":"crossref","DOI":"10.1007\/978-981-13-3642-3_5","article-title":"Peyer\u2019s patch: Targeted drug delivery for therapeutics benefits","volume":"121\u2013149","author":"Patel","year":"2019","journal-title":"Novel Drug Delivery Technologies: Innovative Strategies for Drug Re-positioning"},{"issue":"3","key":"10.1016\/j.vascn.2024.107548_bb0560","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/0016-5085(83)90079-3","article-title":"Effects of colchicine on the intestinal transport of endogenous lipid: Ultrastructural, biochemical, and radiochemical studies in fasting rats","volume":"84","author":"Pavelka","year":"1983","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.vascn.2024.107548_bb0565","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/BF02088571","article-title":"Effect of Pluronic L-81 on intestinal lipoprotein secretion in the rat","volume":"41","author":"Pidlich","year":"1996","journal-title":"Digestive Diseases and Sciences"},{"issue":"1\u20132","key":"10.1016\/j.vascn.2024.107548_bb0570","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0169-409X(01)00151-X","article-title":"Intestinal lymphatic drug transport: An update","volume":"50","author":"Porter","year":"2001","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"17","key":"10.1016\/j.vascn.2024.107548_bb0575","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.2174\/1381612826999201203214247","article-title":"Lymphatic drug transport and associated drug delivery technologies: A comprehensive review","volume":"27","author":"Punjabi","year":"2021","journal-title":"Current Pharmaceutical Design"},{"issue":"3","key":"10.1016\/j.vascn.2024.107548_bb0580","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3390\/pharmaceutics10030147","article-title":"Oral bioavailability and lymphatic transport of pueraria favone-loaded self-emulsifying drug-delivery systems containing sodium taurocholate in rats","volume":"10","author":"Qiao","year":"2018","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.vascn.2024.107548_bb0585","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1007\/s13346-020-00803-7","article-title":"QbD aided development of ibrutinib-loaded nanostructured lipid carriers aimed for lymphatic targeting: Evaluation using chylomicron flow blocking approach","volume":"10","author":"Rangaraj","year":"2020","journal-title":"Drug Delivery and Translational Research"},{"issue":"7","key":"10.1016\/j.vascn.2024.107548_bb0590","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/jphp.12716","article-title":"Comparative pharmacokinetic evaluation of Lopinavir and Lopinavir-loaded solid lipid nanoparticles in hepatic impaired rat model","volume":"69","author":"Ravi","year":"2017","journal-title":"Journal of Pharmacy and Pharmacology"},{"issue":"2","key":"10.1016\/j.vascn.2024.107548_bb0595","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1152\/ajplegacy.1969.217.2.336","article-title":"Does puromycin block release of chylomicrons from the intestine?","volume":"217","author":"Redgrave","year":"1969","journal-title":"American Journal of Physiology-Legacy Content"},{"issue":"3","key":"10.1016\/j.vascn.2024.107548_bb0600","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1021\/ar300039j","article-title":"The challenge to relate the physicochemical properties of colloidal nanoparticles to their cytotoxicity","volume":"46","author":"Rivera-Gil","year":"2012","journal-title":"Accounts of Chemical Research"},{"issue":"22","key":"10.1016\/j.vascn.2024.107548_bb0605","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.2217\/nnm-2021-0137","article-title":"Novel bioemulsomes for baicalin oral lymphatic targeting: Development, optimization and pharmacokinetics","volume":"16","author":"Rizk","year":"2021","journal-title":"Nanomedicine"},{"issue":"1","key":"10.1016\/j.vascn.2024.107548_bb0610","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/0041-008X(68)90133-6","article-title":"Fatty change in organs of the rat treated with colchicine","volume":"13","author":"Rosenbloom","year":"1968","journal-title":"Toxicology and Applied Pharmacology"},{"issue":"23","key":"10.1016\/j.vascn.2024.107548_bb0615","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1111\/bph.15644","article-title":"Validity of cycloheximide chylomicron flow blocking method for the evaluation of lymphatic transport of drugs","volume":"178","author":"Ry\u0161\u00e1nek","year":"2021","journal-title":"British Journal of Pharmacology"},{"issue":"3662","key":"10.1016\/j.vascn.2024.107548_bb0620","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1126\/science.147.3662.1149","article-title":"Protein synthesis inhibition: Mechanism for the production of impaired fat absorption","volume":"147","author":"Sabesin","year":"1965","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.vascn.2024.107548_bb0625","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3109\/17435390.2011.552811","article-title":"Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration","volume":"6","author":"Schleh","year":"2011","journal-title":"Nanotoxicology"},{"key":"10.1016\/j.vascn.2024.107548_bb0630","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s40495-020-00225-6","article-title":"Colchicine in COVID-19: An old drug, new use","volume":"6","author":"Schlesinger","year":"2020","journal-title":"Current Pharmacology Reports"},{"key":"10.1016\/j.vascn.2024.107548_bb0635","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0065-3233(08)60641-5","article-title":"Apolipoprotein B and low-density lipoprotein structure: Implications for biosynthesis of triglyceride-rich lipoproteins","volume":"45","author":"Schumaker","year":"1994","journal-title":"Advances in Protein Chemistry"},{"issue":"5","key":"10.1016\/j.vascn.2024.107548_bb0640","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000065407","article-title":"Modulation of absorption of beta-carotene and tissue accumulation of beta-carotene and vitamin A by different surfactants in rats","volume":"46","author":"Schweigert","year":"2002","journal-title":"Annals of Nutrition and Metabolism"},{"issue":"1","key":"10.1016\/j.vascn.2024.107548_bb0645","doi-asserted-by":"crossref","DOI":"10.1080\/15685551.2022.2028373","article-title":"Aceclofenac-loaded pluronic F108\/L81 mixed polymeric micelles: Effect of HLB on solubilization","volume":"25","author":"Senthilkumar","year":"2022","journal-title":"Designed Monomers and Polymers"},{"issue":"2","key":"10.1016\/j.vascn.2024.107548_bb0650","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1590\/S1984-82502015000200016","article-title":"Dissolution efficiency and bioequivalence study using urine data from healthy volunteers: A comparison between two tablet formulations of cephalexin","volume":"51","author":"dos Serra","year":"2015","journal-title":"Brazilian Journal of Pharmaceutical Sciences"},{"issue":"3","key":"10.1016\/j.vascn.2024.107548_bb0655","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/0005-2760(83)90279-5","article-title":"Vincristine and vinblastine lower plasma cholesterol concentrations in Rhesus monkeys","volume":"752","author":"Sethi","year":"1983","journal-title":"Biochimica et Biophysica Acta (BBA)-Lipids and Lipid Metabolism"},{"issue":"8","key":"10.1016\/j.vascn.2024.107548_bb0660","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1021\/acs.molpharmaceut.6b00226","article-title":"Positively charged surface-modified solid lipid nanoparticles promote the intestinal transport of docetaxel through multifunctional mechanisms in rats","volume":"13","author":"Shi","year":"2016","journal-title":"Molecular Pharmaceutics"},{"issue":"3","key":"10.1016\/j.vascn.2024.107548_bb0665","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1080\/02726351.2020.1750515","article-title":"Development of mebendazole loaded nanostructured lipid carriers for lymphatic targeting: Optimization, characterization, in-vitro and in-vivo evaluation","volume":"39","author":"Shrivastava","year":"2021","journal-title":"Particulate Science and Technology"},{"issue":"3","key":"10.1016\/j.vascn.2024.107548_bb0670","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2174\/1872211312666181008111354","article-title":"Role of porous carriers in the biopharmaceutical performance of solid SMEDDS of canagliflozin","volume":"12","author":"Singh","year":"2018","journal-title":"Recent Patents on Drug Delivery & Formulation"},{"issue":"6","key":"10.1016\/j.vascn.2024.107548_bb0675","doi-asserted-by":"crossref","first-page":"G718","DOI":"10.1152\/ajpgi.1985.248.6.G718","article-title":"Intestinal absorption of 1, 25-dihydroxyvitamin D3 in the rat","volume":"248","author":"Sitrin","year":"1985","journal-title":"American Journal of Physiology. Gastrointestinal and Liver Physiology"},{"issue":"4","key":"10.1016\/j.vascn.2024.107548_bb0680","doi-asserted-by":"crossref","first-page":"G326","DOI":"10.1152\/ajpgi.1982.242.4.G326","article-title":"Comparison of vitamin D and 25-hydroxyvitamin D absorption in the rat","volume":"242","author":"Sitrin","year":"1982","journal-title":"American Journal of Physiology. Gastrointestinal and Liver Physiology"},{"issue":"5","key":"10.1016\/j.vascn.2024.107548_bb0685","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.amjmed.2014.12.010","article-title":"Colchicine: Old and new","volume":"128","author":"Slobodnick","year":"2015","journal-title":"The American Journal of Medicine"},{"issue":"4","key":"10.1016\/j.vascn.2024.107548_bb0690","doi-asserted-by":"crossref","DOI":"10.2217\/nnm-2023-0263","article-title":"Hydroxymethylnitrofurazone lymphatic uptake with nanostructured lipid carrier after oral administration in rats","volume":"19","author":"Souza","year":"2024","journal-title":"Nanomedicine"},{"issue":"21","key":"10.1016\/j.vascn.2024.107548_bb0695","doi-asserted-by":"crossref","first-page":"14839","DOI":"10.1016\/S0021-9258(18)42116-3","article-title":"Lipoprotein assembly. Apolipoprotein B size determines lipoprotein core circumference","volume":"267","author":"Spring","year":"1992","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/j.vascn.2024.107548_bb0700","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1083\/jcb.62.1.90","article-title":"Colchicine-induced inhibition of lipoprotein and protein secretion into the serum and lack of interference with secretion of biliary phospholipids and cholesterol by rat liver in vivo","volume":"62","author":"Stein","year":"1974","journal-title":"The Journal of Cell Biology"},{"issue":"3","key":"10.1016\/j.vascn.2024.107548_bb0705","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/1097-0142(195405)7:3<607::AID-CNCR2820070320>3.0.CO;2-L","article-title":"Colchicine. III. Pathology and hematology in cats and rats","volume":"7","author":"Sternberg","year":"1954","journal-title":"Cancer"},{"key":"10.1016\/j.vascn.2024.107548_bb0710","first-page":"3413","article-title":"Enhanced oral absorption and therapeutic effect of acetylpuerarin based on D-\u03b1-tocopheryl polyethylene glycol 1000 succinate nanoemulsions","volume":"9","author":"Sun","year":"2014","journal-title":"International Journal of Nanomedicine"},{"issue":"3","key":"10.1016\/j.vascn.2024.107548_bb0715","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejps.2011.04.011","volume":"43","author":"Sun","year":"2011","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.vascn.2024.107548_bb0720","series-title":"Pharmacology","first-page":"175","article-title":"Drug excretion","author":"Taft","year":"2009"},{"issue":"2","key":"10.1016\/j.vascn.2024.107548_bb0725","first-page":"723","article-title":"Vinca alkaloid-the second most used alkaloid for cancer treatment-A review","volume":"2","author":"Taher","year":"2017","journal-title":"International Journal of Physiology, Nutrition and Physical Education"},{"key":"10.1016\/j.vascn.2024.107548_bb0730","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.2147\/IJN.S51469","article-title":"Mechanisms of microemulsion enhancing the oral bioavailability of puerarin: Comparison between oil-in-water and water-in-oil microemulsions using the single-pass intestinal perfusion method and a chylomicron flow blocking approach","volume":"8","author":"Tang","year":"2013","journal-title":"International Journal of Nanomedicine"},{"issue":"6","key":"10.1016\/j.vascn.2024.107548_bb0735","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.semarthrit.2008.08.006","article-title":"Colchicine Update: 2008","volume":"38","author":"Terkeltaub","year":"2009","journal-title":"Seminars in Arthritis and Rheumatism"},{"issue":"5","key":"10.1016\/j.vascn.2024.107548_bb0740","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1023\/B:PHAM.0000026428.48103.4f","article-title":"Urinary excretion: Does it accurately reflect relative differences in bioavailability\/systemic exposure when renal clearance is nonlinear?","volume":"21","author":"Thompson","year":"2004","journal-title":"Pharmaceutical Research"},{"issue":"6","key":"10.1016\/j.vascn.2024.107548_bb0745","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.addr.2007.09.007","article-title":"Lipid-based delivery systems and intestinal lymphatic drug transport: A mechanistic update","volume":"60","author":"Trevaskis","year":"2008","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/j.vascn.2024.107548_bb0750","article-title":"The mesenteric lymph duct cannulated rat model: Application to the assessment of intestinal lymphatic drug transport","volume":"97","author":"Trevaskis","year":"2015","journal-title":"JoVE (Journal of Visualized Experiments)"},{"issue":"11","key":"10.1016\/j.vascn.2024.107548_bb0755","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nrd4608","article-title":"From sewer to saviour \u2014 Targeting the lymphatic system to promote drug exposure and activity","volume":"14","author":"Trevaskis","year":"2015","journal-title":"Nature Reviews Drug Discovery"},{"issue":"6","key":"10.1016\/j.vascn.2024.107548_bb0760","doi-asserted-by":"crossref","first-page":"G487","DOI":"10.1152\/ajpgi.1981.241.6.G487","article-title":"Acute inhibition of intestinal lipid transport by Pluronic L-81 in the rat","volume":"241","author":"Tso","year":"1981","journal-title":"American Journal of Physiology. Gastrointestinal and Liver Physiology"},{"issue":"5","key":"10.1016\/j.vascn.2024.107548_bb0765","doi-asserted-by":"crossref","first-page":"G348","DOI":"10.1152\/ajpgi.1980.239.5.G348","article-title":"Effect of hydrophobic surfactant (Pluronic L-81) on lymphatic lipid transport in the rat","volume":"239","author":"Tso","year":"1980","journal-title":"American Journal of Physiology. Gastrointestinal and Liver Physiology"},{"issue":"1","key":"10.1016\/j.vascn.2024.107548_bb0770","doi-asserted-by":"crossref","first-page":"G32","DOI":"10.1152\/ajpgi.1984.247.1.G32","article-title":"Pluronic L-81: A Ppotent inhibitor of the transport of intestinal chylomicrons","volume":"247","author":"Tso","year":"1984","journal-title":"American Journal of Physiology. Gastrointestinal and Liver Physiology"},{"issue":"6","key":"10.1016\/j.vascn.2024.107548_bb0775","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0022-2275(20)41592-5","article-title":"Puromycin inhibition of cholesterol absorption in the rat","volume":"18","author":"Vahouny","year":"1977","journal-title":"Journal of Lipid Research"},{"issue":"1","key":"10.1016\/j.vascn.2024.107548_bb0780","doi-asserted-by":"crossref","first-page":"26895","DOI":"10.1038\/srep26895","article-title":"Formulation optimization of docetaxel loaded self-emulsifying drug delivery system to enhance bioavailability and anti-tumor activity","volume":"6","author":"Valicherla","year":"2016","journal-title":"Scientific Reports"},{"issue":"6","key":"10.1016\/j.vascn.2024.107548_bb0785","first-page":"529","article-title":"The biochemical pathology of inhibition of protein synthesis in vivo. The effects of cycloheximide on hepatic parenchymal cell ultrastructure","volume":"20","author":"Verbin","year":"1969","journal-title":"Laboratory Investigation; A journal Of Technical Methods And Pathology"},{"issue":"1","key":"10.1016\/j.vascn.2024.107548_bb0790","first-page":"111","article-title":"Some observations on the acute histopathologic effects of cycloheximide in vivo","volume":"62","author":"Verbin","year":"1971","journal-title":"The American Journal of Pathology"},{"issue":"1","key":"10.1016\/j.vascn.2024.107548_bb0795","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1080\/10717544.2017.1386730","article-title":"A novel core-shell lipid nanoparticle for improving oral administration of water soluble chemotherapeutic agents: Inhibited intestinal hydrolysis and enhanced lymphatic absorption","volume":"24","author":"Wang","year":"2017","journal-title":"Drug Delivery"},{"key":"10.1016\/j.vascn.2024.107548_bb0800","series-title":"Encyclopedia of toxicology","author":"Wexler","year":"2005"},{"issue":"5","key":"10.1016\/j.vascn.2024.107548_bb0805","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/jat.1198","article-title":"Acute oral toxicity of colchicine in rats: Effects of gender, vehicle matrix and pre-exposure to lipopolysaccharide","volume":"27","author":"Wiesenfeld","year":"2007","journal-title":"Journal of Applied Toxicology: An International Journal"},{"issue":"1","key":"10.1016\/j.vascn.2024.107548_bb0810","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1042\/bst0320055","article-title":"Dietary fatty acids and chylomicron synthesis and secretion","volume":"32","author":"Williams","year":"2004","journal-title":"Biochemical Society Transactions"},{"issue":"4","key":"10.1016\/j.vascn.2024.107548_bb0815","doi-asserted-by":"crossref","first-page":"R969","DOI":"10.1152\/ajpregu.1998.275.4.R969","article-title":"Nutrients regulate diamine oxidase release from intestinal mucosa","volume":"275","author":"Wollin","year":"1998","journal-title":"American Journal of Physiology. Regulatory, Integrative and Comparative Physiology"},{"issue":"2","key":"10.1016\/j.vascn.2024.107548_bb0820","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1080\/03639045.2017.1391831","article-title":"Formulation optimization and the absorption mechanisms of nanoemulsion in improving baicalin oral exposure","volume":"44","author":"Wu","year":"2018","journal-title":"Drug Development and Industrial Pharmacy"},{"key":"10.1016\/j.vascn.2024.107548_bb0825","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.133063","article-title":"Hyaluronic acid nanoparticles for targeted oral delivery of doxorubicin: Lymphatic transport and CD44 engagement","volume":"273","author":"Wu","year":"2024","journal-title":"International Journal of Biological Macromolecules"},{"issue":"2","key":"10.1016\/j.vascn.2024.107548_bb0830","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ijpharm.2016.07.061","article-title":"Microemulsions containing long-chain oil ethyl oleate improve the oral bioavailability of piroxicam by increasing drug solubility and lymphatic transportation simultaneously","volume":"511","author":"Xing","year":"2016","journal-title":"International Journal of Pharmaceutics"},{"issue":"9","key":"10.1016\/j.vascn.2024.107548_bb0835","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1080\/10837450.2019.1646757","article-title":"Development and in vivo evaluation of baicalin-loaded W\/O nanoemulsion for lymphatic absorption","volume":"24","author":"Xu","year":"2019","journal-title":"Pharmaceutical Development and Technology"},{"issue":"10\u221211","key":"10.1016\/j.vascn.2024.107548_bb0840","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.addr.2011.05.019","article-title":"Intestinal lymphatic transport for drug delivery","volume":"63","author":"Y\u00e1\u00f1ez","year":"2011","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/j.vascn.2024.107548_bb0845","doi-asserted-by":"crossref","first-page":"6503","DOI":"10.2147\/IJN.S259993","article-title":"A non-lipolysis nanoemulsion improved oral bioavailability by reducing the first-pass metabolism of raloxifene, and related absorption mechanisms being studied","volume":"15","author":"Ye","year":"2020","journal-title":"International Journal of Nanomedicine"},{"issue":"8","key":"10.1016\/j.vascn.2024.107548_bb0850","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/0006-2952(63)90116-3","article-title":"Inhibition of the synthesis of protein in intact animals by acetoxycycloheximide and a metabolic derangement concomitant with this blockade","volume":"12","author":"Young","year":"1963","journal-title":"Biochemical Pharmacology"},{"issue":"11","key":"10.1016\/j.vascn.2024.107548_bb0855","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.3390\/pharmaceutics15112532","article-title":"Development of a novel in vitro model to study lymphatic uptake of drugs via artificial chylomicrons","volume":"15","author":"Yousef","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.vascn.2024.107548_bb0860","doi-asserted-by":"crossref","first-page":"86","DOI":"10.14227\/DT290222P86","article-title":"Simulated lymphatic fluid for in-vitro assessment in pharmaceutical development","volume":"29","author":"Yousef","year":"2022","journal-title":"Dissolution Technologies"},{"key":"10.1016\/j.vascn.2024.107548_bb0865","doi-asserted-by":"crossref","first-page":"533","DOI":"10.18433\/jpps32222","article-title":"The lymphatic system: A sometimes-forgotten compartment in pharmaceutical sciences","volume":"24","author":"Yousef","year":"2021","journal-title":"Journal of Pharmacy & Pharmaceutical Sciences"},{"issue":"8","key":"10.1016\/j.vascn.2024.107548_bb0870","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/j.apsb.2020.12.022","article-title":"An update on oral drug delivery via intestinal lymphatic transport","volume":"11","author":"Zhang","year":"2021","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"10.1016\/j.vascn.2024.107548_bb0875","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.2147\/IJN.S462374","article-title":"2-Monoacylglycerol mimetic liposomes to promote intestinal lymphatic transport for improving oral bioavailability of dihydroartemisinin","volume":"19","author":"Zheng","year":"2024","journal-title":"International Journal of Nanomedicine"},{"issue":"Suppl. 4","key":"10.1016\/j.vascn.2024.107548_bb0880","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-199200444-00002","article-title":"Preclinical and clinical pharmacology of vinca alkaloids","volume":"44","author":"Zhou","year":"1992","journal-title":"Drugs"}],"container-title":["Journal of Pharmacological and Toxicological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871924000583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871924000583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T07:30:39Z","timestamp":1726731039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056871924000583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":177,"alternative-id":["S1056871924000583"],"URL":"https:\/\/doi.org\/10.1016\/j.vascn.2024.107548","relation":{},"ISSN":["1056-8719"],"issn-type":[{"value":"1056-8719","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding lymphatic drug delivery through chylomicron blockade: A retrospective and prospective analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological and Toxicological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vascn.2024.107548","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107548"}}